DOI QR코드

DOI QR Code

Outcome after Surgery for Metastases to the Pelvic Bone: A Single Institutional Experience

  • Krishnan, Chandra Kumar (Department of Orthopedic Surgery, Seoul National University Hospital) ;
  • Han, Ilkyu (Department of Orthopedic Surgery, Seoul National University Hospital) ;
  • Kim, Han-Soo (Department of Orthopedic Surgery, Seoul National University Hospital)
  • Received : 2016.09.25
  • Accepted : 2016.10.24
  • Published : 2017.03.01

Abstract

Background: The pelvic bone is the most common site of bone metastases following the axial skeleton. Surgery on the pelvic bone is a demanding procedure. Few studies have been published on the surgical outcomes of metastasis to the pelvic bone with only small numbers of patients involved. This study sought to analyze the complications, local progression and survival after surgery for metastasis to the pelvic bone on a larger cohort of patients. Methods: We analyzed 83 patients who underwent surgery for metastases to the pelvic bone between the years 2000 and 2015. There were 41 men and 42 women with a mean age of 55 years. Possible factors that might be associated with complications, local progression and survival were investigated with regard to patient demographics and disease-related and treatment-related variables. Results: The overall complication rate was 16% (13/83). Advanced age (> 55 years, p = 0.034) and low preoperative serum albumin levels (${\leq}39g/L$, p = 0.001) were associated with increased complication rates. In patients with periacetabular disease, the complication rate was higher in those who underwent total hip replacement arthroplasty (THR) than those who did not (p = 0.030). Local progression rate was 46% (37/83). The overall median time to local progression was $26{\pm}14.3months$. The median time from local progression to death was 13 months (range, 0 to 81 months). The local progression-free survival was $52.6%{\pm}6.4%$ at 2 years and $36.4%{\pm}7.6%$ at 5 years, respectively. Presence of skip lesions (p = 0.017) and presence of visceral metastasis (p = 0.027) were found to be significantly associated with local progression. The median survival of all patients was 24 months. The 2-year and 3-year survival rates were $52.5%{\pm}5.9%$ and $35.6%{\pm}6%$, respectively. Metastasis from the kidney, breast, or thyroid or of hematolymphoid origin (p = 0.014), absence of visceral metastasis (p = 0.017) and higher preoperative serum albumin levels (p = 0.009) were associated with a prolonged survival. Conclusions: Advanced age and low serum albumin levels were associated with high complication rates. Local progression after surgery for metastases to the pelvic bone was affected by the presence of skip lesions, not by surgical margins. Primary cancer type, serum albumin level and visceral metastasis influenced survival.

Keywords

Cited by

  1. Long-term patient survival after the surgical treatment of bone and soft-tissue metastases from renal cell carcinoma vol.b100, pp.9, 2017, https://doi.org/10.1302/0301-620x.100b9.bjj-2017-1163.r3
  2. Modified Harrington’s procedure for periacetabular metastases in 89 cases: a reliable method for cancer patients with good functional outcome, especially with long expected survival vol.91, pp.3, 2017, https://doi.org/10.1080/17453674.2020.1732016
  3. Prise en charge opératoire des métastases péri-acétabulaires. Étude rétrospective d’une série multicentrique de 91 arthroplasties totales de hanc vol.106, pp.6, 2020, https://doi.org/10.1016/j.rcot.2020.07.009
  4. Serum albumin level predicts survival after surgical treatment of metastatic femur fractures: a retrospective study vol.15, pp.None, 2020, https://doi.org/10.1186/s13018-020-01632-7
  5. Rapid histological imaging of bone without microtome sectioning using nonlinear microscopy vol.154, pp.None, 2022, https://doi.org/10.1016/j.bone.2021.116254